• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
How immune complexes from certain IgG NAbs and any F(ab')₂ can mediate excessive complement activation.某些 IgG NAbs 和任何 F(ab')₂ 的免疫复合物如何介导过度的补体激活。
Adv Exp Med Biol. 2012;750:186-96. doi: 10.1007/978-1-4614-3461-0_14.
2
Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.含F(ab')(2)的免疫复合物和天然存在的抗铰链区抗体对补体扩增的刺激作用,可能在全身炎症中发挥作用。
Autoimmun Rev. 2008 Jun;7(6):508-13. doi: 10.1016/j.autrev.2008.04.017. Epub 2008 May 12.
3
Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.含人F(ab')2的免疫复合物与抗铰链区天然抗体一起在体外和体内刺激补体扩增。
Mol Immunol. 2008 May;45(10):2951-61. doi: 10.1016/j.molimm.2008.01.029. Epub 2008 Mar 14.
4
The covalent interaction of C3 with IgG immune complexes.C3与IgG免疫复合物的共价相互作用。
Mol Immunol. 1999 Sep-Oct;36(13-14):843-52. doi: 10.1016/s0161-5890(99)00105-4.
5
IgG naturally occurring antibodies stabilize and promote the generation of the alternative complement pathway C3 convertase.天然存在的IgG抗体可稳定并促进替代补体途径C3转化酶的生成。
Mol Immunol. 2005 Jul;42(11):1393-403. doi: 10.1016/j.molimm.2004.12.014. Epub 2005 Feb 16.
6
A small domain (6.5 kDa) of bacterial protein G inhibits C3 covalent binding to the Fc region of IgG immune complexes.细菌蛋白G的一个小结构域(6.5千道尔顿)可抑制C3与IgG免疫复合物Fc区域的共价结合。
Eur J Immunol. 1998 Aug;28(8):2591-7. doi: 10.1002/(SICI)1521-4141(199808)28:08<2591::AID-IMMU2591>3.0.CO;2-P.
7
Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes.人多形核白细胞上C3b受体的膜分布及吸附性胞吞作用
J Exp Med. 1981 Jun 1;153(6):1615-28. doi: 10.1084/jem.153.6.1615.
8
Further evidence for the antibody nature of C3 nephritic factor (C3NeF).C3 肾炎因子(C3NeF)抗体性质的进一步证据。
J Immunol. 1979 Aug;123(2):755-8.
9
Activation of the alternative complement pathway by the immune precipitate formed with F(ab')2 fragment of human IgG antibody.人IgG抗体F(ab')2片段形成的免疫沉淀物激活替代补体途径。
Mol Immunol. 1983 Nov;20(11):1221-6. doi: 10.1016/0161-5890(83)90146-3.
10
The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.在人血清中替代途径激活后,补体成分C3与抗体 - 抗原聚集体的结合。
Biochem J. 1981 May 1;195(2):471-80. doi: 10.1042/bj1950471.

引用本文的文献

1
Effectiveness and Controversy of Convalescent Plasma Therapy for Coronavirus Disease 2019 Patients.2019冠状病毒病患者恢复期血浆治疗的有效性与争议
Infect Dis Immun. 2021 Dec 2;2(1):49-54. doi: 10.1097/ID9.0000000000000033. eCollection 2022 Jan.
2
Severe COVID-19: Drugs and Clinical Trials.重症新型冠状病毒肺炎:药物与临床试验
J Clin Med. 2023 Apr 16;12(8):2893. doi: 10.3390/jcm12082893.
3
The Dual Role of a Polyvalent IgM/IgA-Enriched Immunoglobulin Preparation in Activating and Inhibiting the Complement System.富含多价IgM/IgA的免疫球蛋白制剂在激活和抑制补体系统中的双重作用
Biomedicines. 2021 Jul 14;9(7):817. doi: 10.3390/biomedicines9070817.
4
Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease.新冠康复者血清疗法:一种治疗21世纪疾病的19世纪疗法。
PLoS Pathog. 2020 Aug 12;16(8):e1008735. doi: 10.1371/journal.ppat.1008735. eCollection 2020 Aug.
5
Early safety indicators of COVID-19 convalescent plasma in 5000 patients.5000 例 COVID-19 恢复期血浆治疗的早期安全性指标。
J Clin Invest. 2020 Sep 1;130(9):4791-4797. doi: 10.1172/JCI140200.
6
Pain-associated biomarkers in breast cancer.乳腺癌中与疼痛相关的生物标志物
J Med Life. 2015 Jan-Mar;8(1):32-6.
7
Glycomic signatures on serum IgGs for prediction of postvaccination response.血清免疫球蛋白G上的糖组学特征用于预测疫苗接种后的反应。
Sci Rep. 2015 Jan 23;5:7648. doi: 10.1038/srep07648.

本文引用的文献

1
Neutrophil elastase inhibitor improves survival of rats with clinically relevant sepsis.中性粒细胞弹性蛋白酶抑制剂可改善具有临床相关性脓毒症的大鼠的存活率。
Shock. 2010 May;33(5):526-31. doi: 10.1097/SHK.0b013e3181cc064b.
2
Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia.西维来司他即使在心肌缺血发作后给药,也能减轻大鼠心脏的心肌缺血和再灌注损伤。
Interact Cardiovasc Thorac Surg. 2009 Jun;8(6):629-34. doi: 10.1510/icvts.2008.195933. Epub 2009 Mar 11.
3
Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies.免疫复合物引发小鼠补体替代途径取决于IgG抗体中的N-聚糖。
Arthritis Rheum. 2008 Oct;58(10):3081-9. doi: 10.1002/art.23865.
4
Human anti-IgG1 hinge autoantibodies reconstitute the effector functions of proteolytically inactivated IgGs.人抗IgG1铰链区自身抗体可恢复经蛋白酶水解失活的IgG的效应功能。
J Immunol. 2008 Sep 1;181(5):3183-92. doi: 10.4049/jimmunol.181.5.3183.
5
Usefulness of a selective neutrophil elastase inhibitor (sivelestat) in septic ARDS patients after gastrointestinal surgery.选择性中性粒细胞弹性蛋白酶抑制剂(西维来司他)在胃肠道手术后脓毒症急性呼吸窘迫综合征患者中的有效性
Hepatogastroenterology. 2008 May-Jun;55(84):967-73.
6
Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.含F(ab')(2)的免疫复合物和天然存在的抗铰链区抗体对补体扩增的刺激作用,可能在全身炎症中发挥作用。
Autoimmun Rev. 2008 Jun;7(6):508-13. doi: 10.1016/j.autrev.2008.04.017. Epub 2008 May 12.
7
Role of natural antibodies in immune homeostasis: IVIg perspective.天然抗体在免疫稳态中的作用:静脉注射免疫球蛋白视角
Autoimmun Rev. 2008 Jun;7(6):440-4. doi: 10.1016/j.autrev.2008.04.011. Epub 2008 Apr 28.
8
A neutrophil elastase inhibitor, sivelestat, reduces lung injury following endotoxin-induced shock in rats by inhibiting HMGB1.一种中性粒细胞弹性蛋白酶抑制剂西维来司他,通过抑制高迁移率族蛋白B1(HMGB1)减轻大鼠内毒素诱导性休克后的肺损伤。
Inflammation. 2008 Aug;31(4):227-34. doi: 10.1007/s10753-008-9069-z.
9
Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.含人F(ab')2的免疫复合物与抗铰链区天然抗体一起在体外和体内刺激补体扩增。
Mol Immunol. 2008 May;45(10):2951-61. doi: 10.1016/j.molimm.2008.01.029. Epub 2008 Mar 14.
10
Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid.体外人源和细菌酶对纯化IgG的蛋白水解作用以及类风湿性滑液中内源性IgG特异性蛋白水解片段的检测。
Mol Immunol. 2008 Apr;45(7):1837-46. doi: 10.1016/j.molimm.2007.10.043. Epub 2007 Dec 21.

某些 IgG NAbs 和任何 F(ab')₂ 的免疫复合物如何介导过度的补体激活。

How immune complexes from certain IgG NAbs and any F(ab')₂ can mediate excessive complement activation.

机构信息

Institute of Biochemistry, Swiss Federal Institute of Technology, ETH Hönggerberg, Zurich, Switzerland.

出版信息

Adv Exp Med Biol. 2012;750:186-96. doi: 10.1007/978-1-4614-3461-0_14.

DOI:10.1007/978-1-4614-3461-0_14
PMID:22903675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7123756/
Abstract

In sepsis death follows an excessive inflammatory response involving cytokines and complement that is activated primarily via the amplifying C3/C5 convertase. Excessive stimulation of complement amplification requires IgG-containing or F(ab')₂-containing immune complexes (IC) that capture dimeric C3b on one of their heavy chains or heavy chain fragments. The ability of IgG-IC to capture dimeric C3b by the Fab portion is dependent on an affinity for C3 within the Fab portion, but outside the antigen-binding region. This property is rare among IgG NAbs. In contrast to this, the lack of the Fc portion renders the Fab regions of any F(ab')(2)-IC accessible to nascent C3b, but dimeric C3b deposits only if F(ab')₂-IC form secondary IC with anti-hinge NAbs that rigidify the complex and thereby promote deposition of dimeric C3b. Both types of complexes, C3b₂-IgG-IC and C3b₂-F(ab')₂-IC/anti-hinge NAbs, are potent precursors of alternative C3 convertases and stimulate complement amplification along with properdin up to 750 times more effectively than C3b and properdin. F(ab')₂ fragments are not normally generated, but are formed from NAbs by enzymes from pathogens and neutrophils in sepsis. Unlike IgG-IC F(ab')₂-IC are not cleared by Fc-receptor dependent processes and circulate long enough to form secondary IC with anti-hinge NAbs that rigidify the complexes such that they capture dimeric C3b and gain the potency to stimulate complement amplification.

摘要

在脓毒症中,死亡是由细胞因子和补体引起的过度炎症反应引起的,补体主要通过扩增的 C3/C5 转化酶激活。补体扩增的过度刺激需要 IgG 或 F(ab')₂ 免疫复合物 (IC),这些复合物在其重链或重链片段之一上捕获二聚体 C3b。IgG-IC 通过 Fab 部分捕获二聚体 C3b 的能力取决于 Fab 部分内对 C3 的亲和力,但在抗原结合区域之外。这种特性在 IgG NAbs 中很少见。与此相反,缺乏 Fc 部分会使任何 F(ab')(2)-IC 的 Fab 区域都能接触到新生的 C3b,但只有当 F(ab')₂-IC 与刚性化复合物并促进二聚体 C3b 沉积的铰链抗体重链 NAbs 形成二次 IC 时,才会沉积二聚体 C3b。这两种类型的复合物,C3b₂-IgG-IC 和 C3b₂-F(ab')₂-IC/铰链抗体重链 NAbs,都是替代 C3 转化酶的有效前体,并与调理素一起刺激补体扩增,效率比 C3 和调理素高 750 倍。F(ab')₂ 片段通常不会产生,但在脓毒症中,病原体和中性粒细胞的酶从 NAbs 中形成。与 IgG-IC 不同,F(ab')₂-IC 不会通过 Fc 受体依赖性过程清除,并且循环时间足够长,可与铰链抗体重链 NAbs 形成二次 IC,使复合物刚性化,从而捕获二聚体 C3b 并获得刺激补体扩增的效力。